Hereditary catalepsy in mice is associated with the brain dysmorphology and altered stress response

Behavioural Brain Research

Volumn 243, Issue 1, 2013, Pages 53-60

  Tikhonova, Maria A ^a   Kulikov, Alexander V ^a   Bazovkina, Daria V ^a   Kulikova, Elizabeth A ^a   Tsybko, Anton S ^a   Bazhenova, Ekaterina Yu ^a   Naumenko, Vladimir S ^a   Akulov, Andrey E ^a   Moshkin, Mikhail P ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Brain; Catalepsy; Emotional stress; Mice; MRI; Serotonin

Indexed keywords

CORTICOSTERONE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSMORPHOLOGY; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DIENCEPHALON; EMOTIONAL STRESS; HEREDITARY CATALEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; IMMOBILIZATION STRESS; MALE; MESENCEPHALON; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEROTONIN METABOLISM; TERATOLOGY; THALAMUS;

ANIMALS; BRAIN; CATALEPSY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED AKR; MICE, INBRED CBA; STRESS, PSYCHOLOGICAL;

EID: 84872570569     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.12.057     Document Type: Article

References (64)

1. Dixon A.K. Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. British Journal of Medical Psychology 1998, 71(Pt 4):417-445.
2. Daniels J. Catatonia: clinical aspects and neurobiological correlates. Journal of Neuropsychiatry and Clinical Neurosciences 2009, 21:371-380.
3. Singerman B., Raheja R. Malignant catatonia-a continuing reality. Annals of Clinical Psychiatry 1994, 6:259-266.
4. Caroff S.N., Mann S.C., Keck P.E., Francis A. Residual catatonic state following neuroleptic malignant syndrome. Journal of Clinical Psychopharmacology 2000, 20:257-259.
5. Paparrigopoulos T., Tzavellas E., Ferentinos P., Mourikis I., Liappas J. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. World Journal of Biological Psychiatry 2009, 10:70-73.
6. Porsolt R.D., Moser P.C., Castagne V. Behavioral indices in antipsychotic drug discovery. Journal of Pharmacology and Experimental Therapeutics 2010, 333:632-638.
7. Wadenberg M.L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neuroscience and Biobehavioral Reviews 1996, 20:325-339.
8. Ornstein K., Amir S. Pinch-induced catalepsy in mice. Journal of Comparative and Physiological Psychology 1981, 95:827-835.
9. Kulikov A.V., Kozlachkova E.Y., Maslova G.B., Popova N.K. Inheritance of predisposition to catalepsy in mice. Behavior Genetics 1993, 23:379-384.
10. Kondaurova E.M., Bazovkina D.V., Kulikov A.V., Popova N.K. Selective breeding for catalepsy changes the distribution of microsatellite D13Mit76 alleles linked to the 5-HT serotonin receptor gene in mice. Genes, Brain and Behavior 2006, 5:596-601.
11. Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Popova N.K. Genetic structure of hereditary catalepsy in mice. Genes, Brain and Behavior 2008, 7:506-512.
12. Bazovkina D.V., Kulikova A.V., Kondaurova E.M., Popova N.K. Selection for the predisposition to catalepsy enhances depressive-like traits in mice. Genetika 2005, 41:1222-1228. [in Russian].
13. Tikhonova M.A., Otroshchenko E.A., Kulikov A.V. Effects of chronic fluoxetine treatment on manifestation of sexual motivation and social behavior in mice of ASC line. Rossiiskii Fiziologicheskii Zhurnal Imeni I. M. Sechenova 2010, 96:163-172. [in Russian].
14. Dubrovina N.I., Zinov'ev D.R., Zinov'eva D.V., Kulikov A.V. Learning and extinction of a passive avoidance response in mice with high levels of predisposition to catalepsy. Neuroscience and Behavioral Physiology 2009, 39:475-480.
15. Alperina E.L., Kulikov A.V., Popova N.K., Idova G.V. Immnune response in mice of a new strain ASC (antidepressants sensitive catalepsy). Bulletin of Experimental Biology and Medicine 2007, 144:221-223.
16. Naumenko V.S., Bazovkina D.V., Kondaurova E.M., Zubkov E.A., Kulikov A.V. The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy. Genes, Brain and Behavior 2010, 9:519-524.
17. Tikhonova M.A., Alperina E.L., Tolstikova T.G., Bazovkina D.V., Di V.Y., Idova G.V., et al. Effects of chronic fluoxetine treatment on catalepsy and the immune response in mice with a genetic predisposition to freezing reactions: the roles of types 1A and 2A serotonin receptors and the tph2 and SERT genes. Neuroscience and Behavioral Physiology 2010, 40:521-527.
18. Tikhonova M.A., Lebedeva V.V., Kulikov A.V., Bazovkina D.V., Popova N.K. Effect of imipramine on the behavior and cerebral 5-HT1A serotonin receptors in mice genetically predisposed to catalepsy. Bulletin of Experimental Biology and Medicine 2006, 141:48-50.
19. Tikhonova M.A., Kulikov A.V., Naumenko V.S., Morozova M.V., Bazovkina D.V., Popova N.K. Intracerebral administration of brain-derived neurotrophic factor (BDNF) reduces severity of cataleptic freezing in mice with genetic predisposition to catalepsy. Bulletin of Experimental Biology and Medicine 2009, 148:889-891.
20. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Tikhonova M.A., Kulikov A.V., et al. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 2012, 214:59-67.
21. Popova N.K., Kulikov A.V. On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models. American Journal of Medical Genetics 1995, 60:214-220.
22. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiological Reviews 2009, 89:535-606.
23. Joels M., Baram T.Z. The neuro-symphony of stress. Nature Reviews Neuroscience 2009, 10:459-466.
24. van Praag H.M. Can stress cause depression?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:891-907.
25. Anisman H., Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neuroscience and Biobehavioral Reviews 2005, 29:525-546.
26. Kulikov A.V., Popova N.K. Genetic control of catalepsy in mice. Genetic predisposition to disease 2008, 215-236. Nova Science Publishers, NewYork. S.L. Torres, M.S. Marin (Eds.).
27. Hof P.R., Young W.G. Comparative cytoarchitectonic atlas of the C57BL/6 and 129 Sv mouse brains 2000, Elsevier, Amsterdam.
28. Bhattacharya S.K., Ghosh P. Effect of restraint stress on cannabis-induced catalepsy in rats. Indian Journal of Physiology and Pharmacology 1982, 26:162-167.
29. Antelman S.M., Caggiula A.R., Kocan D., Knopf S., Meyer D., Edwards D.J., et al. One experience with'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Research 1991, 566:276-283.
30. Antelman S.M., Caggiula A.R., Knopf S., Kocan D.J., Edwards D.J. Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs. Psychopharmacology (Berlin) 1992, 107:331-336.
31. Kooy R.F., Verhoye M., Lemmon V., Van Der Linden A. Brain studies of mouse models for neurogenetic disorders using in vivo magnetic resonance imaging (MRI). European Journal of Human Genetics 2001, 9:153-159.
32. Waerzeggers Y., Monfared P., Viel T., Winkeler A., Jacobs A.H. Mouse models in neurological disorders: applications of non-invasive imaging. Biochimica et Biophysica Acta 2010, 1802:819-839.
33. Sawiak S.J., Wood N.I., Williams G.B., Morton A.J., Carpenter T.A. Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease. Neurobiology of Disease 2009, 33:12-19.
34. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008, 42:19-27.
35. McDaniel B., Sheng H., Warner D.S., Hedlund L.W., Benveniste H. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. Neuroimage 2001, 14:1244-1255.
36. aan het Rot M., Mathew S.J., Charney D.S. Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 2009, 180:305-313.
37. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
38. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocrine Reviews 2001, 22:502-548.
39. Tikhonova M.A., Kulikov A.V., Bazovkina D.V., Morozova M.V., Naumenko V.S., Popova N.K. Antidepressant-like effects of central BDNF administration in mice of Antidepressant Sensitive Catalepsy (ASC) strain. Chinese Journal of Physiology 2012, 55:284-293.
40. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiology and Behavior 1990, 47:957-961.
41. Shizuya K., Komori T., Fujiwara R., Miyahara S., Ohmori M., Nomura J. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sciences 1997, 61:135-140. [PL].
42. Mekaouche M., Givalois L., Barbanel G., Siaud P., Maurel D., Malaval F., et al. Chronic restraint enhances interleukin-1-beta release in the basal state and after an endotoxin challenge, independently of adrenocorticotropin and corticosterone release. Neuroimmunomodulation 1994, 1:292-299.
43. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. Journal of Neuroscience 1998, 18:2239-2246.
44. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998, 10:313-318.
45. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., et al. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. Journal of Neuroscience 1995, 15:1961-1970.
46. Kondaurova E.M., Naumenko V.S., Sinyakova N.A., Kulikov A.V. Map3k1, Il6st, Gzmk, and Hspb3 gene coexpression network in the mechanism of freezing reaction in mice. Journal of Neuroscience Research 2011, 89:267-273.
47. Bazovkina D.V., Tibeikina M.A., Kulikov A.V., Popova N.K. Effects of lipopolysaccharide and interleukin-6 on cataleptic immobility and locomotor activity in mice. Neuroscience Letters 2011, 487:302-304.
48. Cordova A., Sureda A., Tur J.A., Pons A. Immune response to exercise in elite sportsmen during the competitive season. Journal of Physiology and Biochemistry 2010, 66:1-6.
49. Pitman D.L., Ottenweller J.E., Natelson B.H. Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habituation. Physiology and Behavior 1988, 43:47-55.
50. Marin M.T., Cruz F.C., Planeta C.S. Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiology and Behavior 2007, 90:29-35.
51. Veen G., Giltay E.J., DeRijk R.H., van Vliet I.M., van Pelt J., Zitman F.G. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism: Clinical and Experimental 2009, 58:821-827.
52. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). New England Journal of Medicine 1988, 319:413-420.
53. Tafet G.E., Bernardini R. Psychoneuroendocrinological links between chronic stress and depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:893-903.
54. Bonilla-Jaime H., Retana-Marquez S., Arteaga-Silva M., Hernandez-Gonzalez M., Vazquez-Palacios G. Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation. Physiology and Behavior 2010, 100:311-315.
55. Schmidt M.V., Scharf S.H., Sterlemann V., Ganea K., Liebl C., Holsboer F., et al. High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 2010, 35:635-643.
56. Marais L., van Rensburg S.J., van Zyl J.M., Stein D.J., Daniels W.M. Maternal separation of rat pups increases the risk of developing depressive-like behavior after subsequent chronic stress by altering corticosterone and neurotrophin levels in the hippocampus. Neuroscience Research 2008, 61:106-112.
57. Brummelte S., Galea L.A. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience 2010, 168:680-690.
58. Schoenfeld T.J., Gould E. Stress, stress hormones, and adult neurogenesis. Experimental Neurology 2012, 233:12-21.
59. Kondaurova E.M., Bazovkina D.V., Kulikov A.V. Study of the association between catalepsy, anxiety, aggression and depressive-like behavior in congenic mice. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 2010, 96:464-471. [in Russian].
60. Bazovkina D.V., Terenina E.E., Kulikov A.V. Effect of selective agonist of serotonin 5-HT1A receptors on defensive behavior in mice with different predisposition to catalepsy. Bulletin of Experimental Biology and Medicine 2010, 150:225-228.
61. Kulikov A.V., Tikhonova M.A., Kulikova E.A., Volcho K.P., Khomenko T.M., Salakhutdinov N.F., et al. A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice. Psychopharmacology (Berlin) 2012, 221:469-478.
62. Kulikov A.V., Kolpakov V.G., Maslova G.B., Kozintsev I., Popova N.K. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats. Psychopharmacology (Berlin) 1994, 114:172-174.
63. Kulikov A.V., Kozlachkova E.Y., Popova N.K. Activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats. Pharmacology Biochemistry and Behavior 1992, 43:999-1003.
64. Sano K., Mishima K., Koushi E., Orito K., Egashira N., Irie K., et al. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 2008, 151:320-328.